Extreme Weather Is Everywhere Now—How to Prepare Your Home

Plus, how AI could help short-staffed fire departments, the silent electronic battleground shaping warfare, and the…

Forbion Raises $2.6 Billion in Boost to European Biotech Industry

Dutch haul comes despite European drugmakers and investors warning the region is losing ground.

Oil Industry’s Bid to Kill Climate Change Lawsuits Faces SCOTUS Skepticism

Plus, why the U.S. to abruptly pulled bombers from a U.K. base and new Trump Account…

Justice Alito Won’t Participate in Supreme Court Case on Climate Change

The decision to step aside is a reversal after the justice previously indicated he wouldn’t recuse…

AI Biotech Enveda Doubles in Value to $2 Billion

Backed by a former J&J CEO, the startup plans to advance its drug candidates into late-stage…

Trump Administration Shift Puts This Corner of Biotech Back in Favor

With the Food and Drug Administration’s hard-liners gone, investors are rushing back into rare-disease bets.

Legend Biotech has tapped a Novartis executive to run the cell-therapy maker, ending a nearly two-month search that began when former CEO Ying Huang resigned in July

Ingrid Zhang is taking the helm of the cancer therapy company, filling a post vacant since…

Chinese biotech companies are training their sights on one of the most lucrative medicines: GLP-1s

Long a maker of low-end generic drugs, the country is now home to biotech firms that…

Big Pharma chiefs constantly hunt for promising biotech drugs to replace expiring blockbusters. But shopping while hungry can lead to expensive, panic-driven mistakes.

Pharmaceutical chiefs are always hunting for drugs to replace expiring blockbusters. But shopping hungry can lead…

Trump Administration Moves to Spare Space Companies From Environmental Reviews

The government reviews study the impact of rocket launches and reentries on surrounding wildlife and their…